Home » Topics » Conferences

Conferences
RSS

Alendronate and etidronate prevent steroid-induced osteoporosis

Nov. 13, 1997

Pharmacokinetics, peripheral antihistaminic and central effects of rupatadine in humans

Nov. 13, 1997

TNFR:Fc evaluated in patients with heart failure

Nov. 13, 1997

Lerisetron: a potent, selective, long-acting and orally effective 5-HT3 antagonist

Nov. 12, 1997

PDE IV inhibitor from Almirall does not stimulate gastric acid secretion in rats

Nov. 12, 1997

Amiodarone derivative may be suitable for long-term use

Nov. 12, 1997

New NHE inhibitor (EMD-85131) shows promise for ischemic heart disease

Nov. 12, 1997

Nonpeptide alphav/beta3 antagonist effective in rabbit model of neointima formation

Nov. 12, 1997

Tedisamil demonstrates favorable activity in patients with angina

Nov. 12, 1997

Potent and selective fibrinogen receptor antagonist presented by DuPont Merck

Nov. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 30, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026